Literature DB >> 14317335

INHIBITION OF THE MOBILIZATION OF FREE FATTY ACIDS FROM ADIPOSE TISSUE IN DIABETES. II. EFFECT OF NICOTINIC ACID AND ACETYLSALICYLATE ON BLOOD GLUCOSE IN HUMAN DIABETICS.

L A CARLSON, J OSTMAN.   

Abstract

Entities:  

Keywords:  ADIPOSE TISSUE; ASPIRIN; DIABETES MELLITUS; FATTY ACID METABOLISM; GLUCOSE TOLERANCE TEST; NICOTINIC ACID; PHARMACOLOGY

Mesh：

Substances：

Year:  1965        PMID： 14317335     DOI： 10.1111/j.0954-6820.1965.tb04252.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN： 0001-6101


× No keyword cloud information.
  9 in total

Review 1.  Antilipolysis as a tool in the study of clinical and experimental diabetes. Lecture for the 1968 Minkowski Award.

Authors:  L A Carlson
Journal:  Diabetologia       Date:  1969-12       Impact factor: 10.122

2.  [Effect of 6-aminonicotinic acid amide on insulin dependant glucose uptake in epididymal fat tissue].

Authors:  F von Bruchhausen; H Herken
Journal:  Naunyn Schmiedebergs Arch Pharmakol Exp Pathol       Date:  1966

3.  [Effects of the intravenous infusion of nicotinic acid on blood concentrations of substrates, metabolites and hormones in juvenile-onset diabetes].

Authors:  D Michaelis; H J Hahn; R Michael; H Schäfer; S Knospe; E Jutzi; P Wulfert
Journal:  Diabetologia       Date:  1970-12       Impact factor: 10.122

4.  The physiology and pharmacology of adipose tissue lipolysis: its inhibition and implications for the treatment of diabetes.

Authors:  E R Froesch
Journal:  Diabetologia       Date:  1967-12       Impact factor: 10.122

5.  Plasma beta-hydroxybutyric acid response to nicotinic acid-induced plasma free fatty acid decrease in man.

Authors:  L A Carlson; J Ostman
Journal:  Diabetologia       Date:  1966-09       Impact factor: 10.122

6.  Extended-release niacin alters the metabolism of plasma apolipoprotein (Apo) A-I and ApoB-containing lipoproteins.

Authors:  Stefania Lamon-Fava; Margaret R Diffenderfer; P Hugh R Barrett; Aaron Buchsbaum; Mawuli Nyaku; Katalin V Horvath; Bela F Asztalos; Seiko Otokozawa; Masumi Ai; Nirupa R Matthan; Alice H Lichtenstein; Gregory G Dolnikowski; Ernst J Schaefer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-06-19       Impact factor: 8.311

Review 7.  Targeting ApoC-III to Reduce Coronary Disease Risk.

Authors:  Sumeet A Khetarpal; Arman Qamar; John S Millar; Daniel J Rader
Journal:  Curr Atheroscler Rep       Date:  2016-09       Impact factor: 5.113

8.  The effect of 3-methyl salicylic (O-cresotinic) acid on plasma insulin and glucose tolerance in diabetic and non-diabetic subjects.

Authors:  D E Hyams; A N Howard; I E Evans; S H Davison
Journal:  Diabetologia       Date:  1971-04       Impact factor: 10.122

9.  Oxylipid Profile of Low-Dose Aspirin Exposure: A Pharmacometabolomics Study.

Authors:  Sandrine Ellero-Simatos; Amber L Beitelshees; Joshua P Lewis; Laura M Yerges-Armstrong; Anastasia Georgiades; Adrie Dane; Amy C Harms; Katrin Strassburg; Faisa Guled; Margriet M W B Hendriks; Richard B Horenstein; Alan R Shuldiner; Thomas Hankemeier; Rima Kaddurah-Daouk
Journal:  J Am Heart Assoc       Date:  2015-10-26       Impact factor: 5.501
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.